NewsSOS
Milwaukee law firm Ademi LLP has opened an investigation into Crinetics Pharmaceuticals, Inc.
(Nasdaq: CRNX) over the company's recently announced transaction with Vertex, examining whether Crinetics' board secured a fair price for public shareholders.
The probe targets possible breaches of fiduciary duty and other violations of law tied to the deal.
Scope of the Investigation Ademi LLP, based in Milwaukee, said it is scrutinizing whether Crinetics' directors met their legal obligations to shareholders in connection with the Vertex transaction.
Keep reading